Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling

Overview of attention for article published in Frontiers in oncology, November 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 17 publications that cite this research output.

17

The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.

Dihydroartemisinin inhibits ATP6 activity, reduces energy metabolism of hepatocellular carcinoma cells, promotes apoptosis and inhibits metastasis via CANX

Article in Oncology Letters (August 2024)

Integrative approach using network pharmacology, bioinformatics, and experimental methods to explore the mechanism of cantharidin in treating colorectal cancer

Article in Naunyn-Schmiedeberg's Archives of Pharmacology (March 2024)

Elucidation of the mechanism of action of ailanthone in the treatment of colorectal cancer: integration of network pharmacology, bioinformatics analysis and experimental validation

Article in Frontiers in Pharmacology (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.